EdiGene
Biotechnology

EdiGene: Funding & valuation

EdiGene has $129M paid in by investors, lenders and donors.

Financials

Funding rounds, investors and revenue on record.

$129MTotal raised
Series BLatest round
2Rounds and grants8 investors
Money by yearUSD, rounds and grants
2021$62M1 record
2020$67M1 record
Largest rounds and grants
$67M
$62M
Investors
上海圣盖柏投资管理合伙企业(有限合伙)
shareholder on the register (清科 zdb)
和谐成长二期(义乌)投资中心(有限合伙)
shareholder on the register (清科 zdb)
北京中经合明投资管理中心(有限合伙)
shareholder on the register (清科 zdb)
北京嘉豪伟业投资中心(有限合伙)
shareholder on the register (清科 zdb)
深圳市松禾成长一号股权投资合伙企业(有限合伙)
shareholder on the register (清科 zdb)
北京为无和他的朋友们投资管理中心(有限合伙)
shareholder on the register (清科 zdb)
Sources: funding announcements, grant and company registers

Money

EdiGene has $129M paid in by investors, lenders and donors.

$129MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Apr 2021 · Series B
$62MPaid
Equity raised
Oct 2020 · Series B
$67MPaid
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".